G. Fattovich

A. Gasbarrini, R. Bruno, G. Filice, 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Core Protein Evolution After Selection of Hepatitis B Precore Mutants and Correlation with Disease Severity

H. Thomas, G. Fattovich, A. Alberti, 1994 .

Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years

G. Fattovich, M. D’Onofrio, F. Donato, 2007, Gut.

IL28B polymorphisms, IP‐10 and viral load predict virological response to therapy in chronic hepatitis C

G. Malerba, R. Bruno, S. Clément, 2011, Alimentary pharmacology & therapeutics.

The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients

G. Brocco, R. Bruno, F. Negro, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Therapy of hepatitis C: Patients with cirrhosis

G. Fattovich, S. Schalm, J. Brouwer, 1997, Hepatology.

HLA-DR expression in liver in human HIV infection.

M. Rugge, G. Fattovich, B. Murer, 2008, Liver.

AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF).

I. Colle, A. Mangia, G. Fattovich, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Gene polymorphism at the interleukin 6 -174 G > C locus affects the outcome of chronic hepatitis B.

G. Fattovich, M. Pirisi, C. Fabris, 2009, The Journal of infection.

Cryoglobulinemia Related to Hepatitis C Virus Infection

A. Sepulveda, G. Fattovich, G. Realdi, 2007, Digestive Diseases and Sciences.

Liver stellate cells in chronic viral hepatitis: the effect of interferon therapy.

M. Rugge, G. Fattovich, A. Alberti, 1996, Journal of hepatology.

Human immunodeficiency virus infection and hepatitis C pathology.

M. Rugge, G. Fattovich, A. Alberti, 2008, Liver.

Early decrease of interferon-γ+ and interleukin-2+ T cells during combination treatment with interferon-α and ribavirin in patients with chronic hepatitis C.

G. Fattovich, G. Pizzolo, M. Krampera, 2000 .

Early decrease of interferon-γ+ and interleukin-2+ T cells during combination treatment with interferon-α and ribavirin in patients with chronic hepatitis C

G. Fattovich, G. Pizzolo, M. Krampera, 2000, American Journal of Gastroenterology.

Hepatitis C virus infection in chronic hepatitis B virus carriers.

G. Fattovich, L. Brollo, A. Alberti, 1991, The Journal of infectious diseases.

Serum procollagen type III peptide in chronic hepatitis B

M. Rugge, G. Fattovich, A. Alberti, 1996, International journal of clinical & laboratory research.

Hepatitis B virus DNA forms in the liver of chronically infected individuals. Relation to replication profile.

G. Fattovich, A. Alberti, G. Realdi, 1989, Journal of hepatology.

Virus and Host Factors in the Evolution of Chronic Hepatitis Type B: Choice of Treatment

G. Fattovich, A. Alberti, G. Realdi, 1987 .

Determinants of disease activity and evolution of chronic hepatitis type B.

G. Fattovich, A. Alberti, G. Realdi, 1987, Annali dell'Istituto superiore di sanita.

Natural History and Prognosis of Hepatitis B

G. Fattovich, 2003, Seminars in liver disease.

Liver disease in chronic hepatitis B virus (HBV) infection: relation to HBeAg and anti-HBe status

M. Rugge, G. Fattovich, A. Alberti, 1983 .

Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

Francesco Donato, G. Fattovich, F. Donato, 2004, Gastroenterology.

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.

A. Bhalla, H. Thomas, F. Nevens, 1997, Gastroenterology.

Natural history of hepatitis B.

G. Fattovich, 2003, Journal of hepatology.

Reduced serum hepcidin levels in patients with chronic hepatitis C.

D. Girelli, N. Martinelli, T. Ganz, 2009, Journal of hepatology.

Visceral leishmaniasis complicating chronic hepatitis B treated with interferon

G. Fattovich, F. Adami, G. Giustina, 1992, Infection.

Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B.

G. Fattovich, A. Alberti, G. Realdi, 1987, The Journal of infectious diseases.

Autoantibodies during alpha-interferon therapy for chronic hepatitis B.

G. Fattovich, L. Brollo, A. Alberti, 1991, Journal of medical virology.

Antibody dependent cellular cytotoxicity (ADCC) in acute hepatitis B and in chronic active hepatitis.

G. Fattovich, G. Realdi, F. Bortolotti, 1978, Clinical and experimental immunology.

Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors.

G. Fattovich, F. Donato, F. Bortolotti, 2008, Journal of hepatology.

LIVER DISEASE IN ANTI-HBe POSITIVE CHRONIC HBsAg CARRIERS AND HEPATITIS C VIRUS

G. Fattovich, L. Brollo, A. Alberti, 1989, The Lancet.

Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: Role of membrane oxidative damage

G. Fattovich, Kodjo Ayi, L. De Franceschi, 2000, Hepatology.

Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti‐HBe in chronic hepatitis type B

M. Rugge, G. Fattovich, L. Brollo, 1986, Hepatology.

Long‐term outcome of hepatitis B e antigen–positive patients with compensated cirrhosis treated with interferon alfa

G. Fattovich, G. Realdi, G. Giustina, 1997, Hepatology.

Epidemiology and natural history of hepatitis B

G. Fattovich, Giovanna Fattovich, Michela Pasino, 2008 .

Long-term effect of low dose recombinant interferon therapy in patients with chronic hepatitis B.

G. Fattovich, L. Brollo, A. Alberti, 1989, Journal of hepatology.

Original contributionEffect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients

E. Christensen, G. Fattovich, G. Realdi, 2002 .

A randomized controlled trial of lymphoblastoid interferon‐α in patients with chronic hepatitis B lacking HBeAg

M. Rugge, G. Fattovich, L. Brollo, 1992, Hepatology.

Natural history and prognostic factors for chronic hepatitis type B.

G. Fattovich, L. Brollo, A. Alberti, 1991, Gut.

Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients

E. Christensen, G. Fattovich, G. Realdi, 2002, American Journal of Gastroenterology.

Long‐term follow‐up of anti‐HBe‐positive chronic active hepatitis B

G Realdi, G. Fattovich, L. Brollo, 1988, Hepatology.

Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta‐analysis

G. Fattovich, F. Donato, E. Raffetti, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Hepatitis B e antigen negative chronic active hepatitis: hepatitis B virus core mutations occur predominantly in known antigenic determinants

H. Thomas, G. Fattovich, A. Alberti, 1995, Journal of viral hepatitis.

Occurrence of hepatocellular carcinoma and decompensation in western european patients with cirrhosis type B

E. Christensen, G. Fattovich, G. Realdi, 1995, Hepatology.

Interferon therapy for the anti-HBe positive form of chronic hepatitis B.

G. Fattovich, A. Alberti, 1994, Antiviral research.

Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis

G. Fattovich, G. Realdi, G. Giustina, 1998, American Journal of Gastroenterology.

Effectiveness of interferon alfa on the clinical course of caucasian patients with viral compensated cirrhosis

G. Fattovich, G. Realdi, G. Giustina, 1996 .

Long‐term outcome of hepatitis B e antigen–positive patients with compensated cirrhosis treated with interferon alfa

G. Fattovich, G. Realdi, G. Giustina, 1997, Hepatology.

The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease.

G. Fattovich, A. Alberti, P. Pontisso, 1995, Journal of hepatology.

Retrospective analysis of the effect of interferon therapy on the clinical outcome of patients with viral cirrhosis

G. Fattovich, A. Alberti, P. Pontisso, 1998, Cancer.

Other clinical studyOccurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B

E. Christensen, G. Fattovich, G. Realdi, 1995 .

Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study

E. Christensen, G. Fattovich, G. Realdi, 1994 .

Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B

E. Christensen, G. Fattovich, G. Realdi, 2000, Gut.

Induction of autoantibodies during alpha interferon treatment in chronic hepatitis B.

G. Fattovich, L. Brollo, A. Alberti, 1992, Archives of virology. Supplementum.

Levamisole therapy in chronic type B hepatitis. Results of a double-blind randomized trial.

M. Rugge, G. Fattovich, L. Brollo, 1986, Gastroenterology.

Autoantibodies during α‐interferon therapy for chronic hepatitis B

G. Fattovich, L. Brollo, A. Alberti, 1991 .

Changes in serum hepatitis B virus (HBV) DNA positivity in chronic HBV infection: results of a long-term follow-up study of 138 patients.

G. Fattovich, A. Alberti, G. Realdi, 1986, The Journal of infectious diseases.

Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.

G. Fattovich, L. Brollo, A. Alberti, 1988, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

Virus replication and liver disease in chronic hepatitis B virus infection

G. Fattovich, A. Alberti, G. Realdi, 1983, Digestive Diseases and Sciences.

Double‐blind, randomized controlled trial of interleukin‐2 treatment of chronic hepatitis B

G. Fattovich, A. Alberti, G. Giustina, 1998, Journal of medical virology.

Hepatitis B virus core protein mutations are concentrated in B cell epitopes in progressive disease and in T helper cell epitopes during clinical remission.

G. Fattovich, M. Thursz, W. Carman, 1997, The Journal of infectious diseases.

Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis.

G. Fattovich, E. Villa, M. Pasino, 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C.

G. Fattovich, S. Milani, C. Paternoster, 2003, Journal of hepatology.

Hepatitis B core antigen (HBcAg) in serum of patients with chronic hepatitis B detected by a modified radioimmunoassay

G. Fattovich, A. Alberti, G. Realdi, 1985, Journal of medical virology.

Abdominal radionuclide aortography with the gamma scintillation camera.

G. Fattovich, A. Marabini, G. Tori, 1970, The British journal of radiology.

Intrahepatic expression of hepatitis B virus antigens: effect of hepatitis C virus infection.

M. Rugge, G. Fattovich, S. Thung, 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Serum HBV-DNA in anti-HBe positive patients detected by filter and liquid phase hybridization assays.

G. Fattovich, L. Brollo, A. Alberti, 1989, Molecular and cellular probes.

Progression to cirrhosis, hepatocellular carcinoma and liver-related mortality in chronic hepatitis B patients in Italy.

G. Fattovich, L. Covolo, F. Donato, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C

G. Fattovich, M. Pirisi, C. Fabris, 2012, Hepatology.

Intracellular distribution of hepatitis B virus core protein expressed in vitro depends on the sequence of the isolate and the serologic pattern.

G. Fattovich, W. Carman, S. Hadziyannis, 2004, The Journal of infectious diseases.

DISTRIBUTION OF IN VITRO EXPRESSED HBV CORE PROTEIN FROM ISOLATES IS DEPENDENT UPON SEQUENCE AND CORRELATES WITH DISEASE PATTERN

G. Fattovich, S. Hadziyannis, E. Dornan, 2004 .

Natural course and prognosis of chronic hepatitis type B

G. Fattovich, 1996 .

Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP).

E. Christensen, J. Sánchez-Tapias, G. Fattovich, 1994, Journal of hepatology.

Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence

G. Fattovich, U. Gelatti, F. Donato, 2006, Oncogene.

Fine specificity of human antibody response to the pres1 domain of hepatitis B virus

G. Fattovich, A. Alberti, P. Pontisso, 1990, Hepatology.

Virological changes in chronic hepatitis type B treated with levamisole.

G. Fattovich, A. Alberti, G. Realdi, 1982, Digestion.

Polymerase-chain-reaction-based semi-quantification of hepatitis D viraemia in patients treated with high doses of α2b interferon

G. Fattovich, A. Alberti, G. Giustina, 1994 .

Influence of GB virus-C/hepatitis G virus infection on the long-term course of chronic hepatitis B.

G. Fattovich, G. Giustina, F. Donato, 2008, Liver.

Levamisole therapy in chronic type hepatitis.

G. Fattovich, A. Alberti, G. Realdi, 1988, Hepatology.

Relevance of serum HBV-DNA in acute and chronic hepatitis type B

G. Fattovich, A. Alberti, G. Realdi, 1985 .

Suppressor cell activity in viral and non-viral chronic active hepatitis.

G. Fattovich, G. Realdi, F. Tremolada, 1980, Clinical and experimental immunology.

Combination therapy with lymphoblastoid interferon and levamisole in chronic hepatitis type B

G. Fattovich, L. Brollo, A. Alberti, 1991 .

Hepatitis C genotypes in patients with dual hepatitis B and C virus infection

G. Fattovich, A. Alberti, P. Pontisso, 1996, Journal of medical virology.

Expression of preS1 and preS2 in the liver of chronic hepatitis B virus carriers.

G. Fattovich, A. Alberti, P. Pontisso, 1988, Journal of hepatology.

HCV genotype 1 subtypes (1a and 1b): similarities and differences in clinical features and therapeutic outcome

A. Andriulli, G. Fattovich, M. Milella, 2014, Hepatology International.

Antibodies to the RNase H domain of hepatitis B virus P protein are associated with ongoing viral replication

G. Fattovich, A. Alberti, H. Will, 1990, Journal of virology.

Effects of interferon plus ribavirin treatment on NF-κB, TGF-β1, and metalloproteinase activity in chronic hepatitis C

M. Rugge, G. Fattovich, P. Capelli, 2006, Modern Pathology.

Efficacy of prolonged 5 million units of interferon in combination with ribavirin for relapser patients with chronic hepatitis C

G. Fattovich, C. Paternoster, G. Tositti, 2003, Journal of viral hepatitis.

Consensus interferon (CIFN) in combination with ribavirin (RBV) for naive patients with chronic hepatitis C: a multicenter study

G. Fattovich, C. Paternoster, A. Tagger, 2002 .

Hepatitis C Virus Infection and Replication in Patients with Hepatocellular Carcinoma

G. Fattovich, A. Alberti, P. Pontisso, 1994 .

Early decrease of interferon-gamma+ and interleukin-2+ T cells during combination treatment with interferon-alpha and ribavirin in patients with chronic hepatitis C.

G. Fattovich, G. Pizzolo, M. Krampera, 2000, The American journal of gastroenterology.

Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe

F. Nevens, G. Fattovich, G. Realdi, 2001, Journal of viral hepatitis.

[Synthetic salmon calcitonin: effectiveness of intravenous treatment of acute pancreatitis and flare-ups of recurrent chronic pancreatitis].

G. Fattovich, P. Baratta, A. Battocchia, 1980, La Clinica terapeutica.

A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone

G. Fattovich, C. Paternoster, G. Tositti, 2004, Journal of viral hepatitis.

12 Hepatitis C and cirrhosis

G. Fattovich, S. Schalm, 2000 .

Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome.

F. Negro, G. Fattovich, L. Covolo, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Genetic Polymorphisms of Vitamin D Pathway Predict Antiviral Treatment Outcome in Slow Responder Naïve Patients with Chronic Hepatitis C

G. Fattovich, M. Pirisi, C. Fabris, 2013, PloS one.

Complementary role of vitamin D deficiency and the interleukin‐28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C

G. Fattovich, M. Pirisi, C. Fabris, 2011, Hepatology.

Genetic polymorphism at the apolipoprotein E locus affects the outcome of chronic hepatitis B

G. Fattovich, M. Pirisi, C. Fabris, 2010, Journal of medical virology.

Accuracy of ultrasound in the detection of liver fibrosis in chronic viral hepatitis.

R. Pozzi Mucelli, G. Fattovich, M. D’Onofrio, 2005, La Radiologia medica.

The novel ss469415590 variant predicts virological response to therapy in patients with chronic hepatitis C virus type 1 infection

F. Negro, G. Fattovich, L. Covolo, 2014, Alimentary pharmacology & therapeutics.

Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon‐based antiviral therapy

G. Fattovich, M. Pirisi, C. Fabris, 2013, Hepatology.

Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis.

G. Fattovich, F. Morisco, P. Andreone, 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Endogenously produced TNF‐α contributes to the expression of CXCL10/IP‐10 in IFN‐λ3‐activated plasmacytoid dendritic cells

G. Fattovich, F. Calzetti, M. Cassatella, 2016, Journal of leukocyte biology.

Will Vitamin D Supplementation Have a Role in the Treatment of Patients with Chronic Hepatitis C

G. Fattovich, C. Fabris, E. Falleti, 2012 .

Risk factors for hepatocellular carcinoma in HCV-cirrhosis: what we know and what is missing.

J. Llovet, G. Fattovich, 2006, Journal of hepatology.

Epidemiological evolution of Chronic Hepatitis Delta in Italy. An analysis of the Master-B cohort

G. Fattovich, A. Nardi, C. Gavrila, 2014 .

Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP).

G Realdi, H. Thomas, F. Nevens, 1997, Journal of hepatology.

Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters

M. Manns, F. Lammert, J. Dufour, 2014, Gut.

Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) Imaging for the Diagnosis of Cirrhosis during Liver Ultrasonography

G. Fattovich, L. Bolondi, F. Piscaglia, 2011, Ultraschall in der Medizin.

Who is more likely to respond to dual treatment with pegylated‐interferon and ribavirin for chronic hepatitis C? A gender‐oriented analysis

R. Bruno, G. Fattovich, A. Alberti, 2013, Journal of viral hepatitis.

Cellular immunity to the hepatitis B virion in acute hepatitis type B.

G. Fattovich, A. Alberti, G. Realdi, 1983, Clinical and experimental immunology.

Serum Ferritin as a Predictor of Treatment Outcome in Patients With Chronic Hepatitis C

M. Massari, G. Fattovich, F. Ferrara, 2009, The American Journal of Gastroenterology.

Prevalence and incidence of cholecystolithiasis in cirrhosis and relation to the etiology of liver disease.

G. Fattovich, A. Alberti, F. Noventa, 1997, Digestion.

Repeat diagnostic paracentesis is unlikely to alter the management of Spontaneous Bacterial Peritonitis

A. Andriulli, G. Fattovich, M. Milella, 2013 .

Natural history of hepatitis B virus infection and disease

S. Zanni, G. Fattovich, N. Olivari, 2005 .

Expert Consensus Conference. The screening for hepatitis C virus infection in adults in Italy, May 5-6, 2005.

A. Andriulli, N. Magrini, G. Fattovich, 2006, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Relationship between HBcAg in serum and liver and HBV replication in patients with HBsAg‐positive chronic liver disease

G. Fattovich, A. Alberti, G. Realdi, 1985, Journal of medical virology.

Hepatitis B virus precore/core variation and interferon therapy

H. Thomas, G. Fattovich, A. Alberti, 1995, Hepatology.

Carriage of the EGF rs4444903 A>G functional polymorphism associates with disease progression in chronic HBV infection

G. Fattovich, M. Pirisi, C. Fabris, 2012, Clinical and experimental immunology.

Toll Like Receptor 4 D299G Associates with Disease Progression in Caucasian Patients with Chronic HBV Infection: Relationship with Gender

G. Fattovich, C. Fabris, E. Falleti, 2013, Journal of Clinical Immunology.

PREDICTION OF OESOPHAGEAL VARICES (OV) IN HEPATIC CIRRHOSIS BY SERUM NON-INVASIVE MARKERS: RESULTS OF A MULTICENTER, INTERNATIONAL STUDY

G. Fattovich, A. Alberti, G. Sebastiani, 2009 .

No inflammation? No cancer! Clear HBV early and live happily.

G. Fattovich, E. Villa, 2010, Journal of hepatology.

Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis

G. Fattovich, A. Alberti, P. Pontisso, 1989, Digestive Diseases and Sciences.

Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting.